Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Biological Chemistry|October 28, 2008
Japanese encephalitis vaccines--needs, flaws and achievementsErich Tauber, Shailesh DewasthalyFrontiers in Immunology|May 7, 2020
Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus InfectionsSabrina Schrauf, Roland Tschismarov, Erich Tauber, et al.Vaccine|February 10, 2009
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 studyElisabeth Schuller, Christoph S Klade, Gabriele Wölfl, et al.Journal of Applied Toxicology : JAT|December 8, 2022
Biodistribution and toxicology evaluation of a recombinant measles Schwarz-based Lassa vaccine in cynomolgus macaquesSabrina Schrauf, Yvonne Tomberger, Sham Nambulli, et al.Pediatric Pulmonology|February 5, 2003
Negative expiratory pressure: a new tool for evaluating lung function in children?Erich Tauber, Tamas Fazekas, Irmgard Eichler, et al.Pediatric Pulmonology|March 29, 2002
Improvements of lung function in cystic fibrosisErich Tauber, Irmgard Eichler, Christian Gartner, et al.Vaccine|September 23, 2008
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51Elisabeth Schuller, Christoph S Klade, Franz X Heinz, et al.Vaccine|June 15, 2010
Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51Katrin Dubischar-Kastner, Susanne Eder, Vera Buerger, et al.Vaccine|April 4, 2006
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjectsChrista Firbas, Bernd Jilma, Erich Tauber, et al.Vaccine|August 10, 2007
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patientsVerena Schlaphoff, Christoph S Klade, Bernd Jilma, et al.Pageof 2